164 related articles for article (PubMed ID: 1847355)
1. SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans.
Purtilo DT; Falk K; Pirruccello SJ; Nakamine H; Kleveland K; Davis JR; Okano M; Taguchi Y; Sanger WG; Beisel KW
Int J Cancer; 1991 Feb; 47(4):510-7. PubMed ID: 1847355
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice.
Okano M; Taguchi Y; Nakamine H; Pirruccello SJ; Davis JR; Beisel KW; Kleveland KL; Sanger WG; Fordyce RR; Purtilo DT
Am J Pathol; 1990 Sep; 137(3):517-22. PubMed ID: 1975985
[TBL] [Abstract][Full Text] [Related]
3. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.
Cannon MJ; Pisa P; Fox RI; Cooper NR
J Clin Invest; 1990 Apr; 85(4):1333-7. PubMed ID: 2156900
[TBL] [Abstract][Full Text] [Related]
6. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
Baiocchi RA; Caligiuri MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
[TBL] [Abstract][Full Text] [Related]
7. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
9. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency.
Mosier DE; Gulizia RJ; Baird SM; Spector S; Spector D; Kipps TJ; Fox RI; Carson DA; Cooper N; Richman DD
Curr Top Microbiol Immunol; 1989; 152():195-9. PubMed ID: 2553338
[TBL] [Abstract][Full Text] [Related]
10. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
[TBL] [Abstract][Full Text] [Related]
11. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10.
Baiocchi RA; Ross ME; Tan JC; Chou CC; Sullivan L; Haldar S; Monne M; Seiden MV; Narula SK; Sklar J
Blood; 1995 Feb; 85(4):1063-74. PubMed ID: 7849294
[TBL] [Abstract][Full Text] [Related]
12. Fine-tuning the EBV+ hu-PBL-SCID xenogeneic chimera model using in vivo superinfection.
Kvell K; Balogh P; Németh P
Pathol Oncol Res; 2000; 6(4):280-6. PubMed ID: 11173661
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Am J Pathol; 1992 Nov; 141(5):1097-113. PubMed ID: 1332484
[TBL] [Abstract][Full Text] [Related]
15. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
[TBL] [Abstract][Full Text] [Related]
17. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal.
Pisa P; Cannon MJ; Pisa EK; Cooper NR; Fox RI
Blood; 1992 Jan; 79(1):173-9. PubMed ID: 1309425
[TBL] [Abstract][Full Text] [Related]
19. Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases.
Purtilo DT; Okano M; Grierson HL
Environ Health Perspect; 1990 Aug; 88():225-30. PubMed ID: 2176975
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.
Dierksheide JE; Baiocchi RA; Ferketich AK; Roychowdhury S; Pelletier RP; Eisenbeis CF; Caligiuri MA; VanBuskirk AM
Blood; 2005 Feb; 105(4):1558-65. PubMed ID: 15498860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
